These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7914477)

  • 1. Abundant TGF alpha precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats.
    Tanno S; Ogawa K
    Carcinogenesis; 1994 Aug; 15(8):1689-94. PubMed ID: 7914477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis.
    Hu Z; Evarts RP; Fujio K; Omori N; Omori M; Marsden ER; Thorgeirsson SS
    Carcinogenesis; 1996 May; 17(5):931-8. PubMed ID: 8640940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
    Miller RT; Cattley RC; Marsman DS; Lyght O; Popp JA
    Carcinogenesis; 1995 Jan; 16(1):77-82. PubMed ID: 7530605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats.
    Park DY; Hwang SY; Suh KS
    Toxicol Pathol; 2001; 29(5):541-9. PubMed ID: 11695571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta.
    Wollenberg GK; Semple E; Quinn BA; Hayes MA
    Cancer Res; 1987 Dec; 47(24 Pt 1):6595-9. PubMed ID: 3499977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis.
    Wang QS; Sabourin CL; Bijur GN; Robertson FM; Stoner GD
    Mol Carcinog; 1996 Feb; 15(2):144-53. PubMed ID: 8599581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
    Moser GJ; Wolf DC; Goldsworthy TL
    Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S; Merlino GT; Ward JM
    Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of high molecular weight transforming growth factor alpha produced by rat hepatocellular carcinoma cells.
    Luetteke NC; Michalopoulos GK; Teixidó J; Gilmore R; Massagué J; Lee DC
    Biochemistry; 1988 Aug; 27(17):6487-94. PubMed ID: 3219349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-alpha expression in rat experimental hepatocarcinogenesis.
    Pérez-Tomás R; Mayol X; Culleré X; Díaz Ruiz C; Domingo J
    Histol Histopathol; 1992 Jul; 7(3):457-62. PubMed ID: 1504466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential distribution of Met and epidermal growth factor receptor in normal and carcinogen-treated rat liver.
    Huitfeldt HS; Skarpen E; Lindeman B; Becher R; Thrane EV; Schwarze PE
    J Histochem Cytochem; 1996 Mar; 44(3):227-33. PubMed ID: 8648082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL; Klaunig JE
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential analysis of chemically induced hepatoma development in rats by two dimensional electrophoresis.
    Wirth PJ; Benjamin T; Schwartz DM; Thorgeirsson SS
    Cancer Res; 1986 Jan; 46(1):400-13. PubMed ID: 3940206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats.
    Masuhara M; Ogasawara H; Katyal SL; Nakamura T; Shinozuka H
    Carcinogenesis; 1993 Aug; 14(8):1579-84. PubMed ID: 8353842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
    Lee TY; Kim KT; Han SY
    Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
    Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
    Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counteracting effects of dexamethasone and alpha 2-macroglobulin on inhibition of proliferation of normal and neoplastic rat hepatocytes by transforming growth factors-beta type 1 and type 2.
    Wollenberg GK; LaMarre J; Semple E; Farber E; Gauldie J; Hayes MA
    Int J Cancer; 1991 Jan; 47(2):311-6. PubMed ID: 1703130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimen.
    Sakairi T; Kobayashi K; Goto K; Okada M; Kusakabe M; Tsuchiya T; Sugimoto J; Sano F; Mutai M
    Toxicol Pathol; 2001; 29(4):479-82. PubMed ID: 11560253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.